Gepirone may increase the sedative activities of Ropinirole. Ropinirole may increase the atrioventricular blocking (AV block) activities of Celiprolol. Alfaxalone may increase the sedative activities of Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Luliconazole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Mecamylamine. Oxazepam may increase the sedative activities of Ropinirole. Ziprasidone may increase the sedative activities of Ropinirole. Methylergometrine may increase the vasoconstricting activities of Ropinirole. The metabolism of Nitric Oxide can be decreased when combined with Ropinirole. Eltanolone may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be decreased when combined with Dihydroergotamine. Scopolamine may increase the sedative activities of Ropinirole. The metabolism of Cyclophosphamide can be decreased when combined with Ropinirole. Gabapentin may increase the sedative activities of Ropinirole. The metabolism of Procainamide can be decreased when combined with Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Nimodipine. The metabolism of Ropinirole can be decreased when combined with Fosamprenavir. The serum concentration of Ropinirole can be increased when it is combined with Tibolone. The risk or severity of adverse effects can be increased when Ropinirole is combined with Spironolactone. The metabolism of Dexmethylphenidate can be decreased when combined with Ropinirole. Etomidate may increase the sedative activities of Ropinirole. Tianeptine may decrease the antihypertensive activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Aliskiren. The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Ropinirole. Brimonidine may increase the sedative activities of Ropinirole. Sevoflurane may increase the sedative activities of Ropinirole. Trifluoperazine may increase the sedative activities of Ropinirole. Chlorpromazine may increase the sedative activities of Ropinirole. The metabolism of Clevidipine can be decreased when combined with Ropinirole. Nabilone may increase the sedative activities of Ropinirole. Esmirtazapine may decrease the antihypertensive activities of Ropinirole. Zonisamide may increase the sedative activities of Ropinirole. The metabolism of Cinacalcet can be decreased when combined with Ropinirole. The metabolism of Erlotinib can be decreased when combined with Ropinirole. The metabolism of Alosetron can be decreased when combined with Ropinirole. Clonidine may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be decreased when combined with Caroxazone. Fentanyl may increase the sedative activities of Ropinirole. The serum concentration of Ropinirole can be decreased when it is combined with Mitotane. The therapeutic efficacy of Ropinirole can be decreased when used in combination with Sarilumab. The metabolism of Ropinirole can be decreased when combined with Diltiazem. The metabolism of Acenocoumarol can be decreased when combined with Ropinirole. The metabolism of Icotinib can be decreased when combined with Ropinirole. The metabolism of Doxazosin can be decreased when combined with Ropinirole. The metabolism of Tacrine can be decreased when combined with Ropinirole. Midazolam may increase the sedative activities of Ropinirole. Ethyl chloride may increase the sedative activities of Ropinirole. Ropinirole may increase the atrioventricular blocking (AV block) activities of Alprenolol. The risk or severity of adverse effects can be increased when Ropinirole is combined with Furosemide. The metabolism of Ropinirole can be decreased when combined with Zucapsaicin. Mepivacaine may increase the sedative activities of Ropinirole. The metabolism of Riluzole can be decreased when combined with Ropinirole. The metabolism of Ropinirole can be decreased when combined with Verapamil. Bromperidol may increase the sedative activities of Ropinirole. The metabolism of Cevimeline can be decreased when combined with Ropinirole. Ritanserin may increase the sedative activities of Ropinirole. Methadone may increase the sedative activities of Ropinirole. The metabolism of Pyrazinamide can be decreased when combined with Ropinirole. The metabolism of Zileuton can be decreased when combined with Ropinirole. Lamotrigine may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Amyl Nitrite. Gabapentin Enacarbil may increase the sedative activities of Ropinirole. The metabolism of Zolmitriptan can be decreased when combined with Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Equol. The metabolism of Ropinirole can be decreased when combined with Erythromycin. The serum concentration of Doxorubicin can be increased when it is combined with Ropinirole. The metabolism of Ropinirole can be decreased when combined with Lobeglitazone. The metabolism of Antipyrine can be decreased when combined with Ropinirole. The metabolism of Triamterene can be decreased when combined with Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Bupropion. Cyproheptadine may increase the sedative activities of Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Conjugated estrogens. The metabolism of Ropinirole can be decreased when combined with Hydracarbazine. The metabolism of Sertraline can be decreased when combined with Ropinirole. Ethyl loflazepate may increase the sedative activities of Ropinirole. Phenytoin may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Ropinirole. The metabolism of Eltrombopag can be decreased when combined with Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Abiraterone. The risk or severity of adverse effects can be increased when Lacidipine is combined with Ropinirole. The metabolism of Almotriptan can be decreased when combined with Ropinirole. Ropinirole may increase the atrioventricular blocking (AV block) activities of Talinolol. Fluticasone propionate may increase the sedative activities of Ropinirole. Agomelatine may increase the sedative activities of Ropinirole. Aripiprazole may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Ropinirole. The metabolism of Ropinirole can be decreased when combined with Nelfinavir. The risk or severity of adverse effects can be increased when Ropinirole is combined with Etacrynic acid. The risk or severity of adverse effects can be increased when Ropinirole is combined with Torasemide. Haloperidol may increase the sedative activities of Ropinirole. Dextromoramide may increase the sedative activities of Ropinirole. Zuclopenthixol may increase the sedative activities of Ropinirole. The metabolism of Menadione can be decreased when combined with Ropinirole. Aceprometazine may increase the sedative activities of Ropinirole. The metabolism of Nicergoline can be decreased when combined with Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Stiripentol. Dimenhydrinate may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be decreased when combined with Ticlopidine. Zopiclone may increase the sedative activities of Ropinirole. Ropinirole may increase the atrioventricular blocking (AV block) activities of Sotalol. The metabolism of Deutetrabenazine can be decreased when combined with Ropinirole. Desipramine may increase the sedative activities of Ropinirole. Amitriptyline may increase the sedative activities of Ropinirole. The metabolism of Flutamide can be decreased when combined with Ropinirole. Ropinirole may increase the atrioventricular blocking (AV block) activities of Bupranolol. The metabolism of Aprindine can be decreased when combined with Ropinirole. The metabolism of Tamsulosin can be decreased when combined with Ropinirole. Pramocaine may increase the sedative activities of Ropinirole. Ropinirole may increase the atrioventricular blocking (AV block) activities of Indenolol. The risk or severity of adverse effects can be increased when Ropinirole is combined with Valsartan. The metabolism of Mirabegron can be decreased when combined with Ropinirole. The metabolism of Nabumetone can be decreased when combined with Ropinirole. Prochlorperazine may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Fosinopril. Flibanserin may increase the sedative activities of Ropinirole. Quazepam may increase the sedative activities of Ropinirole. Hydroxyzine may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be decreased when combined with Darunavir. Perampanel may increase the sedative activities of Ropinirole. Dextropropoxyphene may increase the sedative activities of Ropinirole. The metabolism of Ritonavir can be decreased when combined with Ropinirole. Carbamazepine may increase the sedative activities of Ropinirole. Halazepam may increase the sedative activities of Ropinirole. Lofentanil may increase the sedative activities of Ropinirole. The metabolism of Debrisoquin can be decreased when combined with Ropinirole. Sertindole may increase the sedative activities of Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Fosaprepitant. Tetrodotoxin may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be decreased when combined with Atazanavir. The therapeutic efficacy of Ropinirole can be decreased when used in combination with Pimavanserin.